TOLll FREE: 1-866-611-2665

COVID-19 VACCINE AND PAIN MANAGEMENT INJECTIONS

If you are scheduled for a COVID-19 vaccine, please DO NOT delay it due to a pain management injection. Getting the COVID-19 vaccine should take priority over a pain management injection. However, if you have a COVID-19 vaccination booked or completed within two weeks PRIOR to your scheduled appointment date or within one week AFTER your scheduled appointment date, please call us at 403-777-3122 as your appointment date will need to be changed.

Please contact us at 1-866-611-2665 if you have a confirmed date for your COVID-19 vaccine and are scheduled for one of the following pain management treatments:

The safety of our patients is very important to us and we believe that receiving the COVID-19 vaccine should take priority over pain management treatment. Our recommendation to delay pain management is based on currently available data and recommendations. Once you have re-booked your appointment, you will need to ensure you follow Mayfair Diagnostics’ health and safety precautions when you attend your appointment.

OTHER SAFETY PRECAUTIONS

While it’s no longer mandatory, we do strongly recommend the wearing of masks at all Mayfair Diagnostics clinics, especially for symptomatic patients. We will continue to have level 3 surgical masks available to patients upon request.

Mayfair Diagnostics employees will continue to wear masks in patient-facing areas, as well as maintaining our sanitization protocols. We also recommend you come alone to your appointment, unless you require assistance.

We remain committed to your imaging needs and safety, and to ensuring the safety of our patients, our employees, and our communities. We update our location pages regularly with information about our clinic hours and services. You can also call us at 1-866-611-2665 between 7:30 a.m. to 6 p.m., Monday to Friday, to speak with our Contact Centre booking team.

Related Articles

Mayfair Diagnostics

Calgary

TOLL FREE: 1-866-611-2665

RELATED SERVICES

SHARE THIS ARTICLE

Share on facebook
Share on twitter
Share on linkedin
Share on email